October 10 from 11:45 am – 12:30 pm HST
Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.
Please join expert pulmonologist and keynote speaker Cedric “Jamie” Rutland, MD, and expert radiologist Jonathan Chung, MD, as they discuss the current state of OFEV. Faculty will review the safety and efficacy of OFEV, explore the mechanism of action for nintedanib, present a patient case study, and focus on the crucial role of radiology in the patient journey. This presentation is made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc.
This is a non-CME event and does not qualify for CME, CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2023 conference sessions.
This event is not endorsed by CHEST and does not reflect the views or opinions of CHEST. This presentation is sponsored by and made on behalf of Boehringer Ingelheim Pharmaceuticals, Inc. Presentation content has been reviewed for consistency with FDA guidelines. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.
Cedric “Jamie” Rutland, MD
Rutland Medical Group
CEO and Medical Director
UCR School of Medicine
Assistant Clinical Professor
Jonathan H. Chung, MD
Professor of Radiology
University of California San Diego
San Diego, CA